Published in Virology on February 01, 1972
Cellular immunity against Rous sarcomas of chickens. Preferential reactivity against autochthonous target cells as determined by lymphocyte adherence and cytotoxicity tests in vitro. Proc Natl Acad Sci U S A (1974) 1.08
Moloney leukemia virus-induced cell surface antigen: detection and characterization in sodium dodecyl sulfate gels. Proc Natl Acad Sci U S A (1977) 1.00
Immunity to murine sarcoma virus induced tumours. IV. Direct cellular cytolysis of 51Cr labelled target cells in vitro and analysis of blocking factors which modulate cytotoxicity. Br J Cancer (1975) 0.95
51Cr release microassay for measuring cell-mediated immunity in chickens. Infect Immun (1975) 0.75
Detection of tumor-specific antigens in an equine sarcoid cell line. Infect Immun (1974) 0.75
Enhancement of immunity against RSV-induced sarcomas by generation of hapten-reactive helper T lymphocytes. Immunology (1985) 0.75
Conserving large carnivores: dollars and fence. Ecol Lett (2013) 4.84
The viruses in all of us: characteristics and biological significance of human endogenous retrovirus sequences. Proc Natl Acad Sci U S A (1996) 4.48
Association of viral reverse transcriptase with an enzyme degrading the RNA moiety of RNA-DNA hybrids. Nat New Biol (1971) 3.95
HIV suppression by interleukin-16. Nature (1995) 3.94
Efficacy and safety of thrombolytic therapy after initially unsuccessful cardiopulmonary resuscitation: a prospective clinical trial. Lancet (2001) 3.88
Src Gene product from different strains of avian sarcoma virus: Kinetics and possible mechanism of heat inactivation of protein kinase activity from cells infected by transformation-defective, temperature-sensitive mutant and wild-type virus. Proc Natl Acad Sci U S A (1979) 3.20
Transoesophageal echocardiography shows high risk of gas embolism during laparoscopic hepatic resection under carbon dioxide pneumoperitoneum. Br J Surg (2002) 2.61
Polypeptides of avian RNA tumor viruses. 1. Isolation and physical and chemical analysis. Virology (1970) 2.49
Identification of human endogenous retroviruses with complex mRNA expression and particle formation. Proc Natl Acad Sci U S A (1993) 2.43
Substitution of the thioredoxin system for glutathione reductase in Drosophila melanogaster. Science (2001) 2.40
Evidence that HERV-K is the endogenous retrovirus sequence that codes for the human teratocarcinoma-derived retrovirus HTDV. Virology (1993) 2.32
Early changes in the distribution and organization of microfilament proteins during cell transformation. Cell (1981) 2.25
Oncogenicity of non-transforming mutants of avian sarcoma viruses. J Gen Virol (1973) 2.14
Polypeptides of avian RNA tumor viruses. IV. Components of the viral envelope. Virology (1972) 2.09
Characteristics of the specific cell-mediated immune response in human immunodeficiency virus infection. J Virol (1987) 1.99
Antibodies to simian T-lymphotropic retrovirus type III in African green monkeys and recognition of STLV-III viral proteins by AIDS and related sera. Lancet (1985) 1.96
Identification of a Rev-related protein by analysis of spliced transcripts of the human endogenous retroviruses HTDV/HERV-K. J Virol (1995) 1.91
Antibodies against synthetic peptides as a tool for functional analysis of the transforming protein pp60src. Cell (1983) 1.91
Defective cleavage of a precursor polypeptide in a temperature-sensitive mutant of avian sarcoma virus. Virology (1976) 1.82
Distinguishable transformation-defective phenotypes among temperature-sensitive mutants of Rous sarcoma virus. J Virol (1977) 1.79
Soluble CD4 enhances simian immunodeficiency virus SIVagm infection. J Virol (1990) 1.79
Simian immunodeficiency virus (SIV) from sun-tailed monkeys (Cercopithecus solatus): evidence for host-dependent evolution of SIV within the C. lhoesti superspecies. J Virol (1999) 1.72
Osteosarcoma over the age of forty. Eur J Cancer (2003) 1.65
Studies on mouse leukemia viruses. I. Isolation and characterization of a group-specific antigen. Virology (1969) 1.63
California arbovirus (La Crosse) infections. I. Clinical and laboratory findings in 66 children with meningoencephalitis. Pediatrics (1973) 1.62
Inhibition of HIV-1 replication and NF-kappa B activity by cysteine and cysteine derivatives. AIDS (1991) 1.57
Colloidal gold granules as markers for cell surface receptors in the scanning electron microscope. Experientia (1975) 1.55
Cerebral and extracerebral release of protein S100B in cardiac surgical patients. Anaesthesia (2004) 1.55
Cardiac output measurement by transpulmonary versus conventional thermodilution technique in intensive care patients after coronary artery bypass grafting. J Cardiothorac Vasc Anesth (1998) 1.54
Translation of avian myeloblastosis virus RNA in a cell-free lysate of Escherichia coli. Proc Natl Acad Sci U S A (1972) 1.53
Pseudotyping of murine leukemia virus with the envelope glycoproteins of HIV generates a retroviral vector with specificity of infection for CD4-expressing cells. Proc Natl Acad Sci U S A (1997) 1.53
Polypeptides of avian RNA tumor viruses. V. Analysis of the virus core. Virology (1972) 1.51
Molecularly cloned simian immunodeficiency virus SIVagm3 is highly divergent from other SIVagm isolates and is biologically active in vitro and in vivo. J Virol (1989) 1.49
Isolation of human immunodeficiency virus-related simian immunodeficiency viruses from African green monkeys. Proc Natl Acad Sci U S A (1989) 1.47
The impact of 3-dimensional reconstructions on operation planning in liver surgery. Arch Surg (2000) 1.47
In search of the astrocytic factor(s) modulating blood-brain barrier functions in brain capillary endothelial cells in vitro. Cell Mol Neurobiol (2005) 1.46
Development of a quasispecies of human immunodeficiency virus type 1 in vivo. Proc Natl Acad Sci U S A (1992) 1.44
Origin of group-specific antigen of chicken leukosis viruses. Virology (1966) 1.44
Operative reconstruction of the external and internal genitalia in female patients with bladder exstrophy or incontinent epispadias. J Urol (1995) 1.41
Genome-wide screening, cloning, chromosomal assignment, and expression of full-length human endogenous retrovirus type K. J Virol (1999) 1.39
Characterization of the antibody response specific for the human endogenous retrovirus HTDV/HERV-K. J Virol (1997) 1.37
Familial thymic aplasia. Attempted reconstitution with fetal thymus in a Millipore diffusion chamber. N Engl J Med (1972) 1.37
Human teratocarcinomas cultured in vitro produce unique retrovirus-like viruses. J Gen Virol (1984) 1.36
Immunological studies of the basis for the apathogenicity of simian immunodeficiency virus from African green monkeys. Proc Natl Acad Sci U S A (1990) 1.33
The enhancing effect of the microbial flora on macrophage function and the immune response. A study in germfree mice. J Exp Med (1966) 1.33
Polypeptides of avian RNA tumor viruses. II. Serological characterization. Virology (1970) 1.32
Protection from pathogenic SIVmac challenge following short-term infection with a nef-deficient attenuated virus. Virology (1996) 1.30
Disseminated strongyloidiasis with cerebral involvement. A complication of corticosteroid therapy. Am J Med (1973) 1.30
Group-specific antigenic determinants of the large envelope glycoprotein of avian oncornaviruses. Virology (1975) 1.29
Interleukin-16 stimulates the expression and production of pro-inflammatory cytokines by human monocytes. Immunology (2000) 1.29
Somatotopic organization of human secondary somatosensory cortex. Cereb Cortex (2001) 1.28
Developing national epidemiologic capacity to meet the challenges of emerging infections in Germany. Emerg Infect Dis (2001) 1.26
HERV-K: the biologically most active human endogenous retrovirus family. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 1.26
Neovascularization and the appearance of morphological characteristics of the blood-brain barrier in the embryonic mouse central nervous system. Brain Res Dev Brain Res (1993) 1.24
Localization of alkaline phosphatase in Saccharomyces cerevisiae by means of ultrathin frozen sections. J Ultrastruct Res (1975) 1.24
Simian immunodeficiency virus of African green monkeys is apathogenic in the newborn natural host. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 1.23
Identification of upregulated genes in scrapie-infected brain tissue. J Virol (2000) 1.23
Restricted IgG subclass responses to HTLV-III/LAV and to cytomegalovirus in patients with AIDS and lymphadenopathy syndrome. J Infect Dis (1986) 1.22
Essential role of Bmp7 (snailhouse) and its prodomain in dorsoventral patterning of the zebrafish embryo. Development (2000) 1.22
Strain-specific antigen of the avian leukosis sarcoma virus group. I. Isolation and immunological characterization. Virology (1970) 1.22
Ribosomal RNA in avian leukosis virus particles. Int J Cancer (1971) 1.22
Dog bite, Bacteroides infection, coagulopathy, renal microangiopathy. Ann Intern Med (1977) 1.21
Growing problem of salmonellosis in modern society. Medicine (Baltimore) (1973) 1.21
The majority of neutralizing Abs in HIV-1-infected patients recognize linear V3 loop sequences. Studies using HIV-1MN multiple antigenic peptides. J Immunol (1994) 1.21
Genome analysis and reverse transcriptase activity of human teratocarcinoma-derived retroviruses. J Gen Virol (1987) 1.20
Molecular cloning, sequence, expression, and processing of the interleukin 16 precursor. Proc Natl Acad Sci U S A (1997) 1.19
Establishment and characterization of molecular clones of porcine endogenous retroviruses replicating on human cells. J Virol (2000) 1.19
Astroglial protein S-100 is an early and sensitive marker of hypoxic brain damage and outcome after cardiac arrest in humans. Circulation (2001) 1.19
Impaired specific cellular response to HTLV-III before other immune defects in patients with HTLV-III infection. N Engl J Med (1986) 1.18
Complete nucleotide sequence of a simian immunodeficiency virus from African green monkeys: a novel type of intragroup divergence. Virology (1990) 1.15
Development of vivo of genetic variability of simian immunodeficiency virus. Proc Natl Acad Sci U S A (1991) 1.15
Lack of HIV-1 V3 region sequence diversity in two haemophiliac patients infected with a putative biologic clone of HIV-1. AIDS (1991) 1.14
Magnetic iron oxide particles coated with carboxydextran for parenteral administration and liver contrasting. Pre-clinical profile of SH U555A. Acta Radiol (1997) 1.14
Virion and tumor cell antigens of C-type rna tumor viruses. Adv Cancer Res (1974) 1.13
Crystallization of a multienzyme complex: fatty acid synthetase from yeast. Proc Natl Acad Sci U S A (1969) 1.12
High virus loads in naturally and experimentally SIVagm-infected African green monkeys. Virology (2001) 1.12
Natural human antibodies reactive with primate type-C viral antigens. Proc Natl Acad Sci U S A (1977) 1.12
Lack of dichotomy between virus load of peripheral blood and lymph nodes during long-term simian immunodeficiency virus infection of African green monkeys. Virology (1996) 1.11
Pulse contour analysis versus thermodilution in cardiac surgery patients. Acta Anaesthesiol Scand (2002) 1.11
Characterization of human endogenous retrovirus type K virus-like particles generated from recombinant baculoviruses. Virology (1997) 1.11
Common tumor-specific surface antigens on cells of different species transformed by avian RNA tumor viruses. Virology (1972) 1.10
Studies on California encephalitis in Minnesota. Am J Epidemiol (1970) 1.10
A multicenter double-blind study of three different doses of the new cAMP-phosphodiesterase inhibitor rolipram in patients with major depressive disorder. Neuropsychobiology (1992) 1.10
CD8+ T lymphocytes of African green monkeys secrete an immunodeficiency virus-suppressing lymphokine. Proc Natl Acad Sci U S A (1994) 1.09
The case for a family of reverse transcriptase viruses: Retraviridae. Intervirology (1974) 1.09
The immunosuppressive peptide of HIV-1: functional domains and immune response in AIDS patients. AIDS (1994) 1.08
Evaluation of serum ferritin as a marker for adult Still's disease activity. Ann Rheum Dis (1992) 1.08
Ribonuclease H activity present in purified DNA polymerase from avian myeloblastosis virus. Biochem Biophys Res Commun (1973) 1.06
pp60c-src is a substrate for phosphorylation when cells are stimulated to enter cycle. FEBS Lett (1984) 1.06
Characteristics of Filoviridae: Marburg and Ebola viruses. Naturwissenschaften (1999) 1.05
Investigations on virus production in RSV mammalian tumours. J Gen Virol (1970) 1.05
Reaction of yeast fatty acid synthetase with iodoacetamide. 1. Kinetics of inactivation and extent of carboxamidomethylation. Eur J Biochem (1977) 1.04
Detection of oncornavirus-like particles in HeLa cells. I. Fine structure and comparative morphological classification. Int J Cancer (1974) 1.04
Structural organization of unique retrovirus-like particles budding from human teratocarcinoma cell lines. J Gen Virol (1983) 1.04
Mutational analysis of the simian immunodeficiency virus SIVmac nef gene. J Virol (1991) 1.04
Long-term follow-up after vaginal sacrospinous fixation: patient satisfaction, anatomical results and quality of life. Int Urogynecol J Pelvic Floor Dysfunct (2008) 1.03